Home › Funds › Citadel Advisors › BCAX
Citadel Advisors position in BCAX
BICARA THERAPEUTICS INC · Health Care
Latest position (Q2 2026)302.94K sh
Reported value held$8.99M
Portfolio Weight0.00%
First reportedQ3 2024
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 234.12K | $5.96M | New |
| Q2 2025 | 221.52K | $2.06M | New |
| Q4 2025 | 796.86K | $13.41M | New |
| Q1 2026 | 1.73M | $34.33M | Add |
| Q2 2026 | 302.94K | $8.99M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding BCAX
- BlackRock Inc 3.85M sh · $114.25M · Q2 2026
- Janus Henderson Group 3.33M sh · $66.11M · Q1 2026
- Franklin Resources 1.95M sh · $57.95M · Q2 2026
- Fidelity Management & Research (FMR) 1.89M sh · $56.21M · Q2 2026
- Vanguard Group 2.19M sh · $36.79M · Q4 2025
- Geode Capital Management 1.16M sh · $34.53M · Q2 2026
- JPMorgan Chase & Co 1.02M sh · $29.81M · Q2 2026
- Goldman Sachs Group 520.57K sh · $15.46M · Q2 2026
- D. E. Shaw & Co 498.19K sh · $14.79M · Q2 2026
- Northern Trust Corp 396.34K sh · $11.77M · Q2 2026
- Charles Schwab Investment Management 365.48K sh · $10.85M · Q2 2026
- Bank of America Corp 352.90K sh · $10.48M · Q2 2026